RBC Spoke With Zafgen Management After The Beloranib Patient Death; Here Are The Takeaways
October 14, 2015 at 15:32 PM EDT
Zafgen Inc (NASDAQ: ZFGN) said on Wednesday that a patient has died during a late-stage trial conducted by the company for its Beloranib ...
